Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 71335-3149

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 71335-3149). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-2 (Figure 2)

A line graph depicting the percent maintained over a 6-month period for Esomeprazole Magnesium delayed-release capsules at strengths of 40 mg, 20 mg, and 10 mg, compared with placebo. The y-axis shows percent maintained, and the x-axis shows months. The 40 mg strength shows the highest maintenance rate over time, followed by 20 mg, 10 mg, and placebo.*

FDA Label Image

Figure-3 (Figure 3)

A line graph showing percent maintained over time (months) for Esomeprazole Magnesium delayed-release capsules at 40 mg and 20 mg doses, 10 mg dose, and placebo. The x-axis represents months from 0 to 6, and the y-axis shows percent maintained from 0% to 100%. Different line styles represent each group, with the 40 mg and 20 mg groups maintaining higher percentages over 6 months compared to the 10 mg and placebo groups.*

FDA Label Image

Figure-4 (Figure 4)

A line chart comparing the percent of patients symptom-free over 28 days among three groups: Esomeprazole Magnesium delayed-release capsules 40 mg, 20 mg, and placebo. The 40 mg and 20 mg groups show higher and similar symptom-free percentages over time, while the placebo group remains lower throughout.*

FDA Label Image

Figure-5 (Figure 5)

A line graph depicting the percent of patients symptom-free over a 28-day diary period. The graph compares Esomeprazole Magnesium delayed-release capsules at 40 mg and 20 mg strengths against placebo, showing higher symptom-free percentages for both esomeprazole doses relative to placebo throughout the study period.*

FDA Label Image

Ink1 (Ink1)

Esomeprazole Magnesium 40 mg delayed release capsules in a blister pack. The blister contains several white and light yellow capsules. The product is labeled by Bryant Ranch Prepack with NDC 71335-3149.*

FDA Label Image

Ink2 (Ink2)

Esomeprazole Magnesium 40 mg delayed-release capsules in a blister packaging from Bryant Ranch Prepack. The image shows a strip containing individual capsules sealed in clear plastic blisters with a foil backing. Each capsule contains 40 mg of esomeprazole magnesium for oral administration.*

FDA Label Image

Label (Lbl713353149)

Esomeprazole Magnesium Delayed-Release Capsules USP 40 mg, packaged in a container of 90 capsules. The label includes NDC 71335-3149-1, repackaged by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Yichang Humanwell Oral Solid Dosage Plant. Storage instructions specify 20° to 25°C (68° to 77°F).*

FDA Label Image

Structure (Structure)

Chemical structure diagram of esomeprazole magnesium, showing the molecular arrangement including methoxy, methyl, and sulfoxide functional groups, with magnesium ions and water of hydration indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.